icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Veropharm posts FY 2009 net profit of 1.107 billion roubles

Veropharm posts FY 2009 net profit of 1.107 billion roubles
Russian drugmaker, Veropharm, has posted a FY 2009 net income of 1.107 billion rubles under IFRS.

The bottom line was up 20% year on year, with FY EBITDA rising 6% to 1.389 billion roubles, as FY 2009 sales rose 2% 4.395 billion roubles.

The company highlighted the contribution of its 79 million rouble upgrade of its production facilities as well as noting a 3% rise prescription drugs with over the counter drug sales rising from 9% to 12% of the total sales mix over the course of the year. Veropharm also disclosed that its debts, at 981 million roubles, comprised less than 20% of its net assets.